z-logo
open-access-imgOpen Access
Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice
Author(s) -
Sandrine Belouzard,
Arnaud Machelart,
Valentin Sencio,
Thibaut Vausselin,
Eik Hoffmann,
Nathalie Deboosère,
Yves Rouillé,
Lowiese Desmarets,
Karin Séron,
Adeline Danneels,
Cyril Robil,
Loïc Belloy,
Camille Moreau,
Catherine Piveteau,
Alexandre Biela,
Alexandre Vandeputte,
Séverine Heumel,
Lucie Deruyter,
Julie Dumont,
Florence Leroux,
Ilka Engelmann,
Enag Kazali Alidjinou,
Didier Hober,
Priscille Brodin,
Terence Beghyn,
François Trottein,
Benoît Déprez,
Jean Dubuisson
Publication year - 2022
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1010498
Subject(s) - vero cell , drug repositioning , potency , pharmacology , drug , drug discovery , lung , viral replication , drug development , respiratory tract , virology , covid-19 , antiviral drug , pharmacokinetics , viral load , respiratory system , biology , medicine , virus , pathology , in vitro , bioinformatics , infectious disease (medical specialty) , biochemistry , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom